Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer Meeting Abstract


Authors: Goto, K.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T. M.; Gainor, J. F.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; Peled, N.; Weiss, J.; Kim, Y.; Ohe, Y.; Horiike, A.; Park, K.; Huang, X.; Olek, E.; Subbiah, V.; Drilon, A. E.
Abstract Title: Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Start Page: 185s
Language: English
ACCESSION: WOS:000560368301475
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.3584
Notes: Meeting Abstract: 3584 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
  2. Joshua Weiss
    14 Weiss